Acyclovir sodium and Rash erythematous - a phase IV clinical study of FDA data

Summary:

Rash erythematous is reported as a side effect among people who take Acyclovir sodium (acyclovir sodium), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Prednisone, and have Iron overload.

The phase IV clinical study analyzes which people have Rash erythematous when taking Acyclovir sodium. It is created by eHealthMe based on reports of 1,798 people who have side effects when taking Acyclovir sodium from the FDA, and is updated regularly.

What is Acyclovir sodium?

Acyclovir sodium has active ingredients of acyclovir sodium. eHealthMe is studying from 1,813 Acyclovir sodium users. Check the latest studies of Acyclovir sodium.

What is Rash erythematous?

Rash erythematous (redness of the skin) is found to be associated with 1,808 drugs and 1,905 conditions by eHealthMe. Check the latest studies of Rash erythematous.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

1,798 people reported to have side effects when taking Acyclovir sodium.
Among them, 11 people (0.61%) have Rash erythematous.

Could Acyclovir sodium cause Rash erythematous?

Among these 11 people:

How long have people been on Acyclovir sodium when they have Rash erythematous? *

What is the gender of people who have Rash erythematous when taking Acyclovir sodium? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Rash erythematous when taking Acyclovir sodium? *

What are other drugs people take besides Acyclovir sodium? *

What are other side effects people have besides Rash erythematous? *

Nausea (feeling of having an urge to vomit): 7 people, 63.64%
Stress And Anxiety: 6 people, 54.55%
Pain: 6 people, 54.55%
Weakness: 6 people, 54.55%
Fever: 6 people, 54.55%
Chills (felling of cold): 5 people, 45.45%
Dehydration (dryness resulting from the removal of water): 5 people, 45.45%
Acute Kidney Failure: 5 people, 45.45%
Productive Cough: 5 people, 45.45%
Rashes (redness): 5 people, 45.45%

What are the existing conditions these people have? *

Iron Overload: 2 people, 18.18%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 9.09%
Rashes (redness): 1 person, 9.09%
Hiv Infection: 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir sodium and have Rash erythematous?

- Check whether Rash erythematous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acyclovir sodium:

Acyclovir sodium (1,813 reports)

Browse all side effects of Acyclovir sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash erythematous:

Rash erythematous (1,808 drugs)

Browse all the conditions that are associated with Rash erythematous:

Rash erythematous (1,905 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acyclovir sodium (the active ingredients of Acyclovir sodium) and Acyclovir sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.